Get started
Work

Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer

Year: 2015
Type: article
Abstract: Meeting abstracts Non-clinical and clinical combination studies with GVAX and live-attenuated, double-deleted (LADD) Listeria monocytogenes strains engineered to express tumor-associated antigens resulted in survival benefit and induction of cellular mediated immune responses. In a Phase IIa
DOI: 10.1186/2051-1426-3-s2-p102
Authors: Nitya Nair, Ed Lemmens, Amanda Enstrom, Shih-Yu Chen, Serena Chang, Dung Le, Elizabeth M Jaffee, Holden Maecker, Aimee L Murphy, Dirk G Brockstedt, Chan Whiting
Language: English
Subfield: Immunology
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2193648808
FWCI:
Cites:
Cited by:
Related to: 10